ATNF - 180 Life Sciences Corp.
NASDAQ
->
Healthcare
->
Biotechnology
Palo Alto,
United States
Type: Equity
ATNF price evolution
ATNF
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $0.19 | $1.15 | $0.68 | $1.98 |
| Short term investments | ||||
| Net receivables | $0.04 | $0.01 | $0.01 | $0.45 |
| Inventory | ||||
| Total current assets | $1.23 | $2.35 | $1.85 | $3.64 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | $1.56 | $1.59 | $1.62 | |
| Total noncurrent assets | $1.56 | $1.59 | $1.62 | |
| Total investments | ||||
| Total assets | $10.47 | $3.91 | $3.44 | $5.26 |
| Current liabilities | ||||
| Accounts payable | $2.67 | $2.92 | $1.84 | $2.16 |
| Deferred revenue | ||||
| Short long term debt | $0.43 | $0.77 | $1.03 | |
| Total current liabilities | $6.38 | $4.02 | $4.08 | $5.06 |
| Long term debt | $0.01 | $0.01 | $0.02 | $0.02 |
| Total noncurrent liabilities | $0.31 | $0.32 | $0.32 | |
| Total debt | $0.44 | $0.79 | $1.05 | |
| Total liabilities | $6.74 | $4.33 | $4.4 | $5.39 |
| Shareholders' equity | ||||
| Retained earnings | -$129.24 | -$128.4 | -$128.41 | -$127.34 |
| Other shareholder equity | -$2.98 | -$2.92 | -$2.89 | -$2.9 |
| Total shareholder equity | -$0.42 | -$0.95 | -$0.13 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1.98 | $6.97 | $8.22 | $2.11 |
| Short term investments | ||||
| Net receivables | $0.45 | $0.62 | $0.69 | $0.3 |
| Inventory | ||||
| Total current assets | $3.64 | $8.93 | $11.2 | $4.01 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | $1.62 | $1.66 | $38.94 | $38.95 |
| Total noncurrent assets | $1.62 | $10.72 | $51.51 | $51.52 |
| Total investments | ||||
| Total assets | $5.26 | $19.65 | $62.71 | $55.53 |
| Current liabilities | ||||
| Accounts payable | $2.16 | $1.8 | $0.59 | $8.74 |
| Deferred revenue | ||||
| Short long term debt | $1.03 | $1.31 | $1.91 | $3.67 |
| Total current liabilities | $5.06 | $5.66 | $19.7 | $21.42 |
| Long term debt | $0.02 | $0.03 | $0.05 | $0.11 |
| Total noncurrent liabilities | $0.32 | $2.65 | $3.69 | $3.83 |
| Total debt | $1.05 | $1.34 | $1.96 | $3.78 |
| Total liabilities | $5.39 | $8.31 | $23.39 | $25.25 |
| Shareholders' equity | ||||
| Retained earnings | -$127.34 | -$107.41 | -$68.68 | -$48.36 |
| Other shareholder equity | -$2.9 | -$2.89 | $0.82 | $0.64 |
| Total shareholder equity | -$0.13 | $11.34 | $39.32 | $30.29 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $0.62 | $0.54 | -$0.04 | |
| Selling, general & administrative | $1.22 | $1.56 | $1.49 | |
| Total operating expenses | $0.98 | $1.85 | $2.09 | $1.45 |
| Operating income | -$1.85 | -$2.09 | -$1.45 | |
| Income from continuing operations | ||||
| EBIT | $0.02 | -$1.05 | -$1.22 | |
| Income tax expense | -$0 | |||
| Interest expense | $0.02 | $0.01 | $0.02 | $0.01 |
| Net income | ||||
| Net income | -$0.84 | $0.01 | -$1.07 | -$1.23 |
| Income (for common shares) | $0.01 | -$1.07 | -$1.23 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $2.78 | $2.43 | $3.95 | $2.29 |
| Selling, general & administrative | $10.69 | $15.47 | $11.69 | $3.36 |
| Total operating expenses | $13.48 | $17.9 | $15.64 | $5.65 |
| Operating income | -$13.48 | -$17.9 | -$15.64 | -$5.65 |
| Income from continuing operations | ||||
| EBIT | -$22.24 | -$39.64 | -$20.16 | -$9.82 |
| Income tax expense | -$2.35 | -$0.94 | -$0.02 | -$0.02 |
| Interest expense | $0.04 | $0.03 | $0.19 | $1.09 |
| Net income | ||||
| Net income | -$19.94 | -$38.73 | -$20.32 | -$10.88 |
| Income (for common shares) | -$19.94 | -$38.73 | -$20.32 | -$12.01 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $0.01 | -$1.07 | -$1.23 | |
| Operating activities | ||||
| Depreciation | $0.02 | $0.02 | $0.02 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.02 | $0.24 | $0.5 | |
| Total cash flows from operations | $0.73 | -$1.03 | -$2.16 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.83 | |||
| Net borrowings | -$0.26 | -$0.26 | $0.7 | |
| Total cash flows from financing | -$1.01 | -$0.26 | -$0.26 | $1.47 |
| Effect of exchange rate | -$0.25 | $0.01 | -$0 | $0 |
| Change in cash and equivalents | -$1.78 | $0.47 | -$1.3 | -$0.69 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$19.94 | -$38.73 | -$20.32 | -$10.88 |
| Operating activities | ||||
| Depreciation | $0.11 | $0.11 | $0.11 | $0.13 |
| Business acquisitions & disposals | $3.01 | |||
| Stock-based compensation | $2.19 | $2.63 | $2.85 | $1.12 |
| Total cash flows from operations | -$10.92 | -$12.13 | -$19.37 | -$3.87 |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | $11.48 | |||
| Total cash flows from investing | $14.49 | |||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $6.26 | $11.48 | $24.61 | -$8.93 |
| Net borrowings | -$0.29 | -$0.61 | $0.8 | $0.2 |
| Total cash flows from financing | $5.91 | $10.87 | $25.41 | -$8.73 |
| Effect of exchange rate | $0.02 | -$0 | $0.08 | $0.14 |
| Change in cash and equivalents | -$4.99 | -$1.25 | $6.12 | $2.03 |
News
|
United States shares mixed at close of trade; Dow Jones Industrial Average up...
Investing.com
18 Oct 2024
|
|
Dow Jumps Over 100 Points; Alcoa Profit Beats Estimates - Alcoa (NYSE:AA)
Benzinga
18 Oct 2024
|
|
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving...
Benzinga
17 Oct 2024
|
|
Nasdaq Moves Higher; Morgan Stanley Profit Beats Estimates - Altus Power...
Benzinga
17 Oct 2024
|
|
This biotech stock soared a whopping 900% on Wednesday: find out more | Invezz
Invezz
17 Oct 2024
|
|
10 stocks near their 52-week low
Bankrate via AOL
1 Mar 2024
|
|
10 stocks near their 52-week low
Bankrate via Yahoo Finance
28 Feb 2024
|
|
Miriam Adelson: What you should know about the Dallas Mavericks reported buyer
KDFW via Yahoo News
29 Nov 2023
|
|
Opinion: Why the Kaiser Permanente strike may signal more healthcare labor unrest to come
LA Times via Yahoo News
28 Sep 2023
|
|
Jacksonville to lose one of its nonprofit champions; here's her story
The Florida Times-Union via Yahoo News
27 Jun 2023
|
Fundamentals
| Market cap | $17.25M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.03M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$3.12M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -5.53 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.19 |
| EPS | -$3.04 |
|---|---|
| ROA | -54.10% |
| ROE | N/A |
| Debt/Equity | -42.18 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.19 |
| Quick ratio | N/A |